Free Trial

Neuronetics (STIM) SEC Filings & 10K Form

Neuronetics logo
$3.33 -0.11 (-3.20%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$3.33 0.00 (0.00%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Neuronetics SEC Filings

DateFilerForm TypeView
08/12/2025
3:15 PM
Madryn Asset Management, LP (Filed by)
Neuronetics (Subject)
Form SCHEDULE 13D/A
08/12/2025
3:15 PM
Madryn Asset Management, LP (Reporting)
MADRYN HEALTH ADVISORS GP II, LLC (Reporting)
MADRYN HEALTH ADVISORS II, LP (Reporting)
MADRYN HEALTH PARTNERS II , LP (0002007791) (Reporting)
Madryn Health Partners II, LP (Reporting)
MADRYN SELECT ADVISORS GP, LLC (Reporting)
MADRYN SELECT ADVISORS, LP (Reporting)
Madryn Select Opportunities, LP (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
3:54 PM
Madryn Select Opportunities, LP (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2025
3:52 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2025
3:30 PM
Neuronetics (Filer)
Form 424B5
08/05/2025
6:31 AM
Neuronetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2025
6:10 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2025
11:15 PM
Neuronetics (Filer)
Form EFFECT
07/15/2025
4:00 PM
Neuronetics (Issuer)
Pfanstiel Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
4:00 PM
Neuronetics (Issuer)
Pfanstiel Steven (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/15/2025
6:30 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2025
4:05 PM
Neuronetics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/28/2025
6:11 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
4:05 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
11:54 AM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2025
6:30 AM
Neuronetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
6:10 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2025
3:32 PM
Neuronetics (Filer)
Form DEF 14A
04/10/2025
3:33 PM
Neuronetics (Filer)
Form DEFA14A
03/27/2025
3:35 PM
Neuronetics (Filer)
Form 8-K/A
03/27/2025
3:35 PM
Neuronetics (Filer)
Form PRE 14A
03/27/2025
3:36 PM
Neuronetics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2025
4:24 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4/A
03/13/2025
4:28 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4/A
03/13/2025
4:30 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4/A
03/06/2025
4:00 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:00 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
2:16 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
2:27 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:00 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
4:46 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:48 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
4:49 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:21 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
2:16 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
2:13 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
2:13 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
2:08 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
2:17 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
4:16 PM
Cucuz Sasha (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:18 PM
MUIR GLENN P (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)

Right now, we’re witnessing a monumental shift in the world.tc pixel

Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia.
02/10/2025
4:20 PM
CONLEY SHERYL L (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
2:13 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
2:16 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
2:17 PM
Neuronetics (Subject)
Sullivan Keith J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
5:03 AM
Neuronetics (Filer)
Form 424B5
02/06/2025
4:25 PM
Neuronetics (Filer)
Form 424B5
02/04/2025
4:00 PM
Neuronetics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/13/2025
7:04 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
4:54 PM
Madryn Asset Management, LP (Reporting)
MADRYN HEALTH ADVISORS GP II, LLC (Reporting)
MADRYN HEALTH ADVISORS II, LP (Reporting)
MADRYN HEALTH PARTNERS II , LP (0002007791) (Reporting)
Madryn Health Partners II, LP (Reporting)
MADRYN SELECT ADVISORS GP, LLC (Reporting)
MADRYN SELECT ADVISORS, LP (Reporting)
Madryn Select Opportunities, LP (Reporting)
Neuronetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2024
4:00 PM
Cucuz Sasha (Reporting)
Neuronetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2024
4:00 PM
Amin Avinash (Reporting)
Neuronetics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2024
8:15 PM
Madryn Asset Management, LP (Filed by)
Neuronetics (Subject)
Form SC 13D
12/12/2024
4:00 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:00 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:00 PM
Neuronetics (Issuer)
Sullivan Keith J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:45 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
1:32 PM
Kent Lake PR LLC (Filed by)
Neuronetics (Subject)
Form SCHEDULE 13G
11/14/2024
10:32 AM
Neuronetics (Subject)
Parian Global Management LP (Filed by)
Form SCHEDULE 13G/A
11/14/2024
10:17 AM
Divisadero Street Capital Management, LP (Filed by)
Neuronetics (Subject)
Form SC 13G/A
11/13/2024
5:44 AM
Neuronetics (Filer)
Form 8-K/A
11/12/2024
6:31 AM
Neuronetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
6:01 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:03 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:01 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:18 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:20 PM
Neuronetics (Filer)
Form DEFA14A
10/10/2024
4:05 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
4:05 PM
Furlong Stephen (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:30 PM
Neuronetics (Filer)
Form DEFA14A
10/08/2024
2:19 PM
MACAN WILLIAM ANDREW (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
2:20 PM
Furlong Stephen (Reporting)
Neuronetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
4:06 PM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
7:54 AM
Neuronetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
7:56 AM
Neuronetics (Filer)
Form DEFA14A
10/04/2024
6:34 AM
Neuronetics (Filer)
Form DEFM14A
09/17/2024
6:32 AM
Neuronetics (Filer)
Form PREM14A
09/13/2024
4:02 PM
CASCELLA ROBERT (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
4:05 PM
MUIR GLENN P (Reporting)
Neuronetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:STIM) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners